Skip to content
CO
Company

Updated:

Clovis Oncology, Inc.

Clovis Oncology, Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001466301, and its reported industry...

Overview

Clovis Oncology, Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001466301, and its reported industry is Pharmaceutical Preparations. In 10-K filed on 2022-02-24, it reported annual revenue of USD 148,757,000; net income of USD -264,524,000; total assets of USD 472,833,000 for the fiscal period ended 2021-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

Company overview

Legal name
Clovis Oncology, Inc.
Classification
Company
Industry (SIC)
2834 — Pharmaceutical Preparations
Headquarters
Boulder, CO, United States
Incorporated in
DE
Fiscal year end
December 31
SEC CIK
0001466301

Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

Fiscal yearPeriod endRevenueNet incomeTotal assetsCash and equivalentsOperating cash flow
FY2021USD$148.8M-$264.5M$472.8M$143.4M-$196.1M
FY2020USD$164.5M-$369.2M$605.6M$240.2M-$252.7M
FY2019USD$143.0M-$400.4M$669.6M$161.8M-$323.6M
FY2018USD$95.4M-$368.0M$863.6M$221.9M-$366.0M

Recent SEC filings

FormFiledPeriodFiling
8-K8-K
8-K8-K
8-K8-K
8-K8-K
8-K8-K
8-K8-K
8-K8-K
8-K8-K
8-K8-K
8-K8-K
8-K8-K
8-K8-K

Profile maintained by Altss. Updated: . To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.

Research Clovis Oncology, Inc. in Altss

Track this company’s investors, transactions and relationships in Altss.

Book a demo

More Company profiles

Clovis Oncology, Inc. | Boulder Company | Altss